FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study

被引：0
|
作者：
Alberto Zaniboni
Enrico Aitini
Sandro Barni
Daris Ferrari
Stefano Cascinu
Vincenzo Catalano
Giuseppe Valmadre
Domenica Ferrara
Enzo Veltri
Claudio Codignola
Roberto Labianca
机构：
[1] Fondazione Poliambulanza,Medical Oncology Unit
[2] C. Poma Hospital,Medical Oncology Unit
[3] Treviglio-Caravaggio Hospital,Medical Oncology Unit
[4] S. Paolo Hospital,Medical Oncology Unit
[5] Università Politecnica delle Marche,Medical Oncology Unit
[6] Ospedali Riuniti di Ancona,Medical Oncology Unit
[7] Ospedali Riuniti Marche Nord,Medical Oncology DH
[8] Presidio San Salvatore,Medical Oncology Unit
[9] Ospedale di Sondalo,Medical Oncology Unit
[10] Ospedale San Carlo,Department of Surgery
[11] Ospedale Don Luigi di Liegro,Medical Oncology Unit
[12] Fondazione Poliambulanza,undefined
[13] Ospedali Riuniti,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词：
Pancreatic cancer; FOLFIRI; Chemotherapy; Second-line; Irinotecan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1641 / 1645
页数：4
相关论文
共 50 条
  • [41] SORAFENIB DOES NOT IMPROVE THE RESULTS OF CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER: A GISCAD RANDOMISED PHASE II TRIAL
    Berardi, R.
    Sobrero, A.
    Labianca, R.
    Bidoli, P.
    Siena, S.
    Ferrari, D.
    Barni, S.
    Cengarle, R.
    Monteforte, M.
    Cascinu, S.
    ANNALS OF ONCOLOGY, 2010, 21 : 225 - 225
  • [42] A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic Cancer
    Cardin, Dana B.
    Thota, Ramya
    Goff, Laura W.
    Berlin, Jordan D.
    Jones, Clyde M.
    Ayers, Gregory D.
    Whisenant, Jennifer G.
    Chan, Emily
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (08): : 772 - 776
  • [43] A Phase II Trial of nab-Paclitaxel as Second-line Therapy in Patients With Advanced Pancreatic Cancer
    Hosein, Peter J.
    Lopes, Gilberto de Lima, Jr.
    Pastorini, Vitor H.
    Gomez, Christina
    Macintyre, Jessica
    Zayas, Gloria
    Reis, Isildinha
    Montero, Alberto J.
    Merchan, Jaime R.
    Lima, Caio M. Rocha
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (02): : 151 - 156
  • [44] A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agent
    Christos Fountzilas
    Ravi Chhatrala
    Nikhil Khushalani
    Wei Tan
    Charles LeVea
    Alan Hutson
    Chris Tucker
    Wen Wee Ma
    Graham Warren
    Patrick Boland
    Renuka Iyer
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 497 - 505
  • [45] A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agent
    Fountzilas, Christos
    Chhatrala, Ravi
    Khushalani, Nikhil
    Tan, Wei
    LeVea, Charles
    Hutson, Alan
    Tucker, Chris
    Ma, Wen Wee
    Warren, Graham
    Boland, Patrick
    Iyer, Renuka
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (03) : 497 - 505
  • [46] MULTICENTER PHASE II STUDY OF SECOND-LINE?FOLFIRI plus CETUXIMAB WITH KRAS WILD TYPE GENE IN METASTATIC CRC?FLIER)
    Kato, T.
    Iwamoto, S.
    Hazama, S.
    Matsuda, C.
    Inagaki, H.
    Amagai, K.
    Nagata, N.
    Sakamoto, J.
    Mishima, H.
    ANNALS OF ONCOLOGY, 2010, 21 : 195 - 195
  • [47] SECOND-LINE CHEMOTHERAPY IN ADVANCED CANCER OF THE PANCREAS: A MULTICENTER SURVEY OF THE GRUPPO ONCOLOGICO ITALIA MERIDONALE ON THE ACTIVITY AND SAFETY OF THE FOLFIRI REGIMEN IN CLINICAL PRACTICE
    Arcara, C.
    Maiello, E.
    Giuliani
    Borsellino, N.
    Gebbia, V.
    Colucci, G.
    EJC SUPPLEMENTS, 2008, 6 (14): : 119 - 119
  • [48] Retrospective analysis of second-line chemotherapy after Folfirinox failure in advanced pancreatic cancer
    Chikhareva, Y.
    Fedyanin, M.
    Bazin, I.
    Pokataev, I.
    Manukyan, M.
    Kantieva, D.
    Tryakin, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S131 - S131
  • [49] Second-line chemotherapy for advanced gastric cancer in Korea
    Sun Kyung Baek
    Si-Young Kim
    Jae-heon Jeong
    Kyung San Cho
    Hwi-Joong Yoon
    Gastric Cancer, 2012, 15 : 345 - 354
  • [50] Second-line chemotherapy in advanced pancreatic cancer: A retrospective, single-center analysis
    Herrmann, T.
    Jaeger, D.
    Stremmel, W.
    Herrmann, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345